NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
5.16
+0.32 (6.61%)
At close: Aug 1, 2025, 4:00 PM
5.06
-0.10 (-1.94%)
After-hours: Aug 1, 2025, 7:31 PM EDT
NeoGenomics Employees
NeoGenomics had 2,200 employees as of December 31, 2024. The number of employees increased by 100 or 4.76% compared to the previous year.
Employees
2,200
Change (1Y)
100
Growth (1Y)
4.76%
Revenue / Employee
$313,268
Profits / Employee
-$47,290
Market Cap
666.56M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,200 | 100 | 4.76% |
| Dec 31, 2023 | 2,100 | 0 | - |
| Dec 31, 2022 | 2,100 | 100 | 5.00% |
| Dec 31, 2021 | 2,000 | 300 | 17.65% |
| Dec 31, 2020 | 1,700 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NEO News
- 3 days ago - NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy - Business Wire
- 3 days ago - NeoGenomics, Inc. (NEO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - NeoGenomics Reports Second Quarter 2025 Results - Business Wire
- 4 weeks ago - NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 - Business Wire
- 4 weeks ago - NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care - Business Wire
- 5 weeks ago - NeoGenomics Appoints Dr. Marjorie Green to Board of Directors - Business Wire
- 2 months ago - NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025 - Business Wire
- 2 months ago - NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer - Business Wire